Abstract
Drug information (DI) resource requirements differ between states and practice setting or specialty. The objective of this study was to determine each state's legal requirements for maintaining DI resources in a pharmacy according to general or specialty practice. All 50 states in the United States, the District of Columbia, and Puerto Rico were targeted to identify their mandated DI resources. General resources were required by 50 boards of pharmacy (or jurisdictions) (96.2%), whereas 43 (82.6%) specified site- or practice-specific resources. Minnesota and South Dakota (3.8%) required print references. Forty (76.9%) required current laws or regulations. Other specifications include allowances for journals (7.7%), requirements for herbal medicine information (7.7%), and a resource in support of immunization administration (5.8%). This study details DI references mandated in the United States. Pharmacists should be aware that their state and area of practice may dictate which DI resources they must maintain to be in compliance with relevant laws.
| Original language | English |
|---|---|
| Pages (from-to) | 569-582 |
| Number of pages | 14 |
| Journal | Therapeutic Innovation & Regulatory Science |
| Volume | 42 |
| Issue number | 6 |
| DOIs | |
| State | Published - Nov 2008 |
ASJC Scopus Subject Areas
- Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
- Public Health, Environmental and Occupational Health
- Pharmacology (medical)
Keywords
- Board of pharmacy
- Books
- Drug information: Federal law
- Legal
- References: Resources
- State law